Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
Clinical trial NCT00003924 · UNKNOWN
Trial details
- NCT number
- NCT00003924
- Sponsor
- Lymphoma Study Association
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1995-10-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.